Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Henk · SciRah

Researcher profile · Semantic Scholar

H. Henk

Share profile

H. Henk — researcher profile on SciRah

h-index: 32
Works: 144
Citations: 3,884

Most-cited papers

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs
T. Darkow, H. Henk, Simu K. Thomas, W. Feng +4 more
2012PharmacoEconomics (Auckland)268 citations
Semantic Scholar
Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use.
M. Jeffery, W. Hooten, E. Hess, E. Meara +5 more
2017Annals of Emergency Medicine111 citations Open access
Semantic Scholar
An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non–Small-Cell Lung Cancer
M. Stewart, A. Norden, N. Dreyer, H. Henk +14 more
2019JCO Clinical Cancer Informatics103 citations Open access
Semantic Scholar
Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
A. Naeim, H. Henk, L. Becker, V. Chia +3 more
2013BMC Cancer84 citations Open access
Semantic Scholar
Health care costs and resource utilization, including patient burden, associated with novel-agent-based treatment versus other therapies for multiple myeloma: findings using real-world claims data.
A. Teitelbaum, Abbie Ba-Mancini, Hui Huang, H. Henk
2013The Oncologist69 citations Open access
Semantic Scholar
Some cautions on the use of instrumental variables estimators in outcomes research: how bias in instrumental variables estimators is affected by instrument strength, instrument contamination, and sample size.
W. Crown, H. Henk, D. Vanness
2011Value in Health68 citations Open access
Semantic Scholar
The Friends of Cancer Research Real‐World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R Rivera, H. Henk, E. Garrett-Mayer, J. Christian +23 more
2021Clinical pharmacology and therapy53 citations Open access
Semantic Scholar
Patterns of biologic agent utilization among patients with rheumatoid arthritis: a retrospective cohort study
S. Ogale, E. Hitraya, H. Henk
2011BMC Musculoskeletal Disorders53 citations Open access
Semantic Scholar
Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
R. Selby, B. Borah, H. Mcdonald, H. Henk +2 more
2012Thrombosis Research44 citations
Semantic Scholar
A population-based study of immunotherapy-related toxicities in lung cancer
E. Cathcart-Rake, L. Sangaralingham, H. Henk, N. Shah +2 more
2020Clinical Lung Cancer43 citations Open access
Semantic Scholar
Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis
B. D. Smith, C. Beach, D. Mahmoud, L. Weber +1 more
2014Experimental Hematology & Oncology34 citations Open access
Semantic Scholar
Real-world analysis of tyrosine kinase inhibitor treatment patterns among patients with chronic myeloid leukemia in the United States.
H. Henk, M. Woloj, M. Shapiro, J. Whiteley
2015Clinical Therapeutics33 citations
Semantic Scholar
Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment
M. Herberts, T. Teague, V. Thao, L. Sangaralingham +4 more
2023BMC Pulmonary Medicine31 citations Open access
Semantic Scholar
Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry
O. Baser, Wen-Hui Wei, H. Henk, A. Teitelbaum +1 more
2012Current Medical Research and Opinion31 citations
Semantic Scholar
Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting
E. Buysman, W. Chow, H. Henk, M. Rupnow
2015Current Medical Research and Opinion25 citations
Semantic Scholar
Comparative effectiveness of pegfilgrastim, filgrastim, and sargramostim prophylaxis for neutropenia-related hospitalization: two US retrospective claims analyses
H. Henk, L. Becker, Hiangkiat Tan, J. Yu +4 more
2013Journal of Medical Economics25 citations Open access
Semantic Scholar
Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
P. Noseworthy, H. Van Houten, H. Krumholz, D. Kent +9 more
2022Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease24 citations Open access
Semantic Scholar
A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia
H. Henk, C. Paoli, S. Gandra
2015Advances in Therapy24 citations Open access
Semantic Scholar
Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees
Eric J. Chow, D. Doody, J. Wilkes, L. Becker +5 more
2020Leukemia and Lymphoma22 citations Open access
Semantic Scholar
Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-based Modeling Study, 2011-2014
Grace Mahoney, H. Henk, R. McCoy
2019Mayo Clinic proceedings22 citations Open access
Semantic Scholar
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
Molly M. Jeffery, W. Hooten, H. Henk, M. Bellolio +4 more
2018British medical journal22 citations Open access
Semantic Scholar
Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
E. Buysman, W. Chow, H. Henk, M. Rupnow
2015BMC Endocrine Disorders20 citations Open access
Semantic Scholar
Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma
H. Henk, A. Teitelbaum, J. Pérez, S. Kaura
2012American journal of hematology/oncology19 citations
Semantic Scholar
Evaluation of the clinical benefit of long-term (beyond 2 years) treatment of skeletal-related events in advanced cancers with zoledronic acid
H. Henk, A. Teitelbaum, S. Kaura
2012Current Medical Research and Opinion18 citations
Semantic Scholar
Long-term anti-Mullerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors
B. Zhou, B. Kwan, Milli J. Desai, V. Nalawade +6 more
2022Fertility and Sterility16 citations Open access
Semantic Scholar
Novel Type 2 Diabetes Medication Access and Effect of Patient Cost Sharing
H. Henk, Janice M. S. Lopez, B. Bookhart
2018Journal of Managed Care & Specialty Pharmacy15 citations Open access
Semantic Scholar
Treatment patterns and healthcare costs among patients with advanced non-small-cell lung cancer
H. Henk, S. Ray
201314 citations
Semantic Scholar
Association of Generic Imatinib Availability and Pricing With Trends in Tyrosine Kinase Inhibitor Use in Patients With Chronic Myelogenous Leukemia.
G. Lyman, H. Henk
2020JAMA Oncology11 citations Open access
Semantic Scholar
Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies.
J. Wilkes, G. Lyman, D. Doody, S. Chennupati +5 more
2020JCO Oncology Practice11 citations Open access
Semantic Scholar
First-, second- and third-line lung cancer treatment patterns and associated costs in a US healthcare claims database
S. Ramsey, H. Henk, Gregory Smith, J. Sollano +1 more
201511 citations
Semantic Scholar
Retrospective evaluation of the clinical benefit of long-term continuous use of zoledronic acid in patients with lung cancer and bone metastases
H. Henk, S. Kaura, A. Teitelbaum
2012Journal of Medical Economics11 citations Open access
Semantic Scholar
Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
A. Naeim, H. Henk, L. Becker, Victoria Chia +3 more
2013BMC Cancer10 citations Open access
Semantic Scholar
Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population
H. Henk, Connie Chen, Á. Benedict, J. Sullivan +1 more
2013ClinicoEconomics and Outcomes Research10 citations Open access
Semantic Scholar
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan
H. Henk, S. Kaura
2012Journal of Medical Economics10 citations Open access
Semantic Scholar
Time to diagnosis among young patients with cancer
Lena E. Winestone, J. Wilkes, D. Puccetti, T. Keegan +9 more
2024Pediatric Blood & Cancer9 citations Open access
Semantic Scholar
Real-world Canagliflozin Utilization: Glycemic Control Among Patients With Type 2 Diabetes Mellitus-A Multi-Database Synthesis.
W. Chow, G. Miyasato, F. Kokkotos, R. Bailey +2 more
2016Clinical Therapeutics8 citations
Semantic Scholar
Assessment of zoledronic acid treatment patterns and clinical outcomes in patients with bone metastases from genitourinary cancers
H. Henk, S. Kaura
2012Journal of Medical Economics8 citations Open access
Semantic Scholar
Canagliflozin treatment of Hispanic and non-Hispanic patients with type 2 diabetes in a US managed care setting
W. Chow, E. Buysman, M. Rupnow, R. Aguilar +1 more
2016Current Medical Research and Opinion7 citations
Semantic Scholar
Retrospective study of patients with metastatic triple-negative breast cancer: survival, health care utilization, and cost
O. Baser, Wen-Hui Wei, Lin Xie, H. Henk +1 more
20127 citations
Semantic Scholar
Maternal Comorbidity and Adverse Perinatal Outcomes in Adolescent and Young Adult Cancer Survivors: a Cohort Study
Milli J. Desai, Beth Zhou, V. Nalawade, C. Gyamfi-Bannerman +5 more
2023BJOG: an International Journal of Obstetrics and Gynaecology6 citations Open access
Semantic Scholar
Correction: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis
B. D. Smith, C. Beach, D. Mahmoud, L. Weber +1 more
2014Experimental Hematology & Oncology6 citations Open access
Semantic Scholar
Expenditures among young adults with acute lymphoblastic leukemia by site of care
J. Wolfson, S. Bhatia, J. Ginsberg, L. Becker +8 more
2021Cancer5 citations Open access
Semantic Scholar
Estimating recommended gonorrhea and chlamydia treatment rate using linked medical claims, prescription and laboratory data in US private settings.
G. Tao, K. Workowski, Katherine E. Bowden, W. Pearson +3 more
2020Sexually Transmitted Diseases4 citations
Semantic Scholar
Burden of Early-Stage Triple-Negative Breast Cancer in a US Managed Care Plan
O. Baser, Wen-Hui Wei, H. Henk, A. Teitelbaum +1 more
20124 citations
Semantic Scholar
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) Population
A. Ganguli, H. Henk, A. Teitelbaum, S. Ray
20114 citations Open access
Semantic Scholar
Sexually Transmitted Infection Testing and Prevalence Before and After Preexposure Prophylaxis Initiation Among Men Aged ≥18 Years in US Private Settings
G. Tao, W. Pearson, J. Sullivan, H. Henk +1 more
2021Sexually Transmitted Diseases3 citations Open access
Semantic Scholar
Comparative effectiveness of colony-stimulating factors in febrile neutropenia prophylaxis: how results are affected by research design.
H. Henk, Xiaoyan Li, L. Becker, Hairong Xu +3 more
2015Journal of Comparative Effectiveness Research3 citations
Semantic Scholar
277 An observational study of treatment utilization and its variation by age in patients with MDS
H. Henk, D. Mahmoud, Z. Khan
20112 citations
Semantic Scholar
UnitedHealthcare’s Approach to Digitally Enabled Health Solutions: Pragmatic Trials to Identify Real Value
N. Morden, Jacob Van Elswyk, H. Henk, A. V. Pirrello +1 more
2025NEJM Catalyst1 citations
Semantic Scholar
BAR MIGRATION IN DRYLAND RIVER WITH HIGH-DISCHARGE VARIABILITY, THE DEGREY RIVER, NORTHWESTERN AUSTRALIA
M. Moorhead, J. Holbrook, H. Henk, S. Lang +3 more
2022Geological Society of America Abstracts with Programs1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Teitelbaum×9
Invite
A. Teitelbaum — researcher profile on SciRah
L. Becker×7
Invite
L. Becker — researcher profile on SciRah
S. Kaura×5
Invite
S. Kaura — researcher profile on SciRah
R. Deeter×4
Invite
R. Deeter — researcher profile on SciRah

×4

Invite

E. Buysman — researcher profile on SciRah

Invite

W. Chow — researcher profile on SciRah

Invite

J. Wilkes — researcher profile on SciRah

Lena E. Winestone×4

Invite

Lena E. Winestone — researcher profile on SciRah

Invite

G. Lyman — researcher profile on SciRah

Invite

N. Shah — researcher profile on SciRah

Invite

A. Naeim — researcher profile on SciRah

Invite

Xiaoyan Li — researcher profile on SciRah